Product logins

Find logins to all Clarivate products below.


์ƒ๋ช…๊ณผํ•™ ๋ฐ ํ—ฌ์Šค์ผ€์–ด

์‹ ๋ขฐํ•  ์ˆ˜ ์žˆ๋Š”
์ธํ…”๋ฆฌ์ „์Šค๋ฅผ
๊ธฐ๋ฐ˜์œผ๋กœ
๋ณด๋‹ค ๊ฑด๊ฐ•ํ•œ ๋ฏธ๋ž˜๋ฅผ
๊ตฌ์ถ•ํ•˜์„ธ์š”

์•ˆ์ „ํ•˜๊ณ  ํšจ๊ณผ์ ์ด๋ฉฐ ์ƒ์—…์ ์œผ๋กœ ์„ฑ๊ณต์ ์ธ ์น˜๋ฃŒ์ œ๋ฅผ ๋ณด๋‹ค ์‹ ์†ํ•˜๊ฒŒ ํ™˜์ž์—๊ฒŒ ์ œ๊ณตํ•˜์„ธ์š”

์ตœ์‹  ์ •๋ณด

2024๋…„ ASCO์—์„œ ์ฃผ๋ชฉ๋ฐ›์€ ์˜์•ฝํ’ˆ๋“ค 2024๋…„ ASCO์—์„œ ์ฃผ๋ชฉ๋ฐ›์€ ์˜์•ฝํ’ˆ๋“ค
๋ณด๊ณ ์„œ
2024๋…„ ASCO์—์„œ ์ฃผ๋ชฉ๋ฐ›์€ ์˜์•ฝํ’ˆ๋“ค
ASCO์—ฐ๋ก€ ํšŒ์˜์— ์ œ์ถœ๋œ 5์ฒœ์—ฌ๊ฐœ๊ฐ€ ๋„˜๋Š” ์ดˆ๋ก์„ ๊ฒ€ํ† ํ•ด ์ฃผ๋ชฉํ• ๋งŒํ•œ 10๊ฐœ์˜ ์—ฐ๊ตฌ๊ฒฐ๊ณผ์™€ ํ•จ๊ป˜ ๋น ๋ฅด๊ฒŒ ์„ฑ์žฅํ•˜๊ณ  ์žˆ๋Š” ์ค‘๊ตญ์‹œ์žฅ์—์„œ ๋‚˜ํƒ€๋‚œ 5๊ฐœ์˜ ์—ฐ๊ตฌ ๊ฒฐ๊ณผ๋ฅผ ์ถ”๋ฆฐ ํ›„ ๊ฐ๊ฐ์˜ ๋งฅ๋ฝ, ์ฃผ์š”๊ฒฐ๊ณผ ๋ฐ ์ž ์žฌ์ ์ธ ์˜ํ–ฅ์— ๋Œ€ํ•ด ๋‹ค๋ค„๋ด…๋‹ˆ๋‹ค.
2024๋…„ ์ฃผ๋ชฉํ•ด์•ผ ํ•  ์˜๋ฃŒ๊ธฐ์ˆ  2024๋…„ ์ฃผ๋ชฉํ•ด์•ผ ํ•  ์˜๋ฃŒ๊ธฐ์ˆ 
๋ณด๊ณ ์„œ
2024๋…„ ์ฃผ๋ชฉํ•ด์•ผ ํ•  ์˜๋ฃŒ๊ธฐ์ˆ 
๊ธฐ์กด ํ‘œ์ค€ ์น˜๋ฃŒ๋ฒ•์„ ํ˜์‹ ์ ์œผ๋กœ ๋ฐœ์ „์‹œํ‚ค๊ณ  ํ–ฅ์ƒ๋œ ์น˜๋ฃŒ๊ฒฐ๊ณผ๋ฅผ ์–ป์„ ์ˆ˜ ์žˆ๋Š” ์˜๋ฃŒ๊ธฐ์ˆ ์„ ์ง‘์ค‘์ ์œผ๋กœ ๋‹ค๋ฃจ๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.
7๊ฐœ์˜ ADC ๊ธฐ์—…๋“ค์ด ๋‚œ์น˜์„ฑ ์•”์— ๋Œ€ํ•œ ์ƒˆ๋กœ์šด ๊ฐ€๋Šฅ์„ฑ์„ ๋ณด์—ฌ์ฃผ๋Š” ์น˜๋ฃŒ์ œ๋ฅผ ๊ฐœ๋ฐœํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค. 7๊ฐœ์˜ ADC ๊ธฐ์—…๋“ค์ด ๋‚œ์น˜์„ฑ ์•”์— ๋Œ€ํ•œ ์ƒˆ๋กœ์šด ๊ฐ€๋Šฅ์„ฑ์„ ๋ณด์—ฌ์ฃผ๋Š” ์น˜๋ฃŒ์ œ๋ฅผ ๊ฐœ๋ฐœํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.
๋ณด๊ณ ์„œ June 19, 2024
7๊ฐœ์˜ ADC ๊ธฐ์—…๋“ค์ด ๋‚œ์น˜์„ฑ ์•”์— ๋Œ€ํ•œ ์ƒˆ๋กœ์šด ๊ฐ€๋Šฅ์„ฑ์„ ๋ณด์—ฌ์ฃผ๋Š” ์น˜๋ฃŒ์ œ๋ฅผ ๊ฐœ๋ฐœํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.
๋ˆˆ์— ๋„์ง€ ์•Š์•˜๋˜ ADCํ˜์‹ ๊ธฐ์—…์— ๋Œ€ํ•ด ์•Œ์•„๋ณด์„ธ์š”.
Emerging deal making trends in biotech and pharma
Placeholder content. Coming 10/9.
chevron_left
chevron_right

์˜์•ฝํ’ˆ ๋ฐ ์˜๋ฃŒ๊ธฐ๊ธฐ ๋ผ์ดํ”„์‚ฌ์ดํด์˜ ๋ชจ๋“  ๋‹จ๊ณ„์— ๋Œ€ํ•œ ์ „๋ฌธ๊ฐ€์˜ ๊ฐ€์ด๋“œ ๋ฐ ์†”๋ฃจ์…˜

๊ด‘๋ฒ”์œ„ํ•˜๊ณ  ์ „๋ฌธํ™”๋œ ์น˜๋ฃŒ ๋ถ„์•ผ ๋ฐ์ดํ„ฐ์™€ ๋งฅ๋ฝ์— ๋งž์ถ˜ ์ธ์‚ฌ์ดํŠธ๋ฅผ ๋ฐ”ํƒ•์œผ๋กœ ๊ตฌ์ถ•๋œ ์ธ๊ณต์ง€๋Šฅ๊ธฐ๋ฐ˜ ์ธํ…”๋ฆฌ์ „์Šค ํ”Œ๋žซํผ์„ ํ™œ์šฉํ•ด ์ž์‹ ์žˆ๊ฒŒ ํ™˜์ž ์ค‘์‹ฌ์˜ ์Šค๋งˆํŠธํ•œ ์˜์‚ฌ๊ฒฐ์ •์„ ๋‚ด๋ฆฌ๋Š” ํ•œํŽธ, ์˜์‚ฌ๊ฒฐ์ • ๊ณผ์ •์—์„œ์˜ ๋‚œ๊ด€์„ ํšจ๊ณผ์ ์œผ๋กœ ํ•ด๊ฒฐํ•˜์‹ญ์‹œ์˜ค.

์ž์‚ฐ ๋ฐ ํฌํŠธํด๋ฆฌ์˜ค ๊ฐ€์น˜ ์ฐฝ์ถœ ์ž์‚ฐ ๋ฐ ํฌํŠธํด๋ฆฌ์˜ค ๊ฐ€์น˜ ์ฐฝ์ถœ
์ž์‚ฐ ๋ฐ ํฌํŠธํด๋ฆฌ์˜ค ๊ฐ€์น˜ ์ฐฝ์ถœ
์—…๊ณ„ ์ตœ๊ณ ์˜ ๋ฐ์ดํ„ฐ, ์‹ค์ œ ์ฆ๊ฑฐ ๋ฐ ์ „๋ฌธ ์ง€์‹์„ ์—ฐ๊ฒฐํ•˜๋Š” ํ˜์‹ ์ ์ธ ์ธํ…”๋ฆฌ์ „์Šค๋ฅผ ํ™œ์šฉํ•˜์—ฌ ์น˜๋ฃŒ์˜ ์šฐ์„ ์ˆœ์œ„๋ฅผ ์ •ํ•˜์„ธ์š”.
์ „๋žต, ๋น„์ฆˆ๋‹ˆ์Šค ๋ฐ ๊ฒฝ์Ÿ ์ธํ…”๋ฆฌ์ „์Šค ํŒ€์ด ์ „๋ฌธ ์ง€์‹, ๋ฐ์ดํ„ฐ ๋ฐ AI ๊ธฐ๋ฐ˜ ๋„๊ตฌ๋ฅผ ํ†ตํ•ด ์ •ํ™•ํ•œ ์˜ˆ์ธก, ํˆฌ์ž ๊ฒ€์ฆ ๋ฐ ๊ฑฐ๋ž˜ ์ตœ์ ํ™”๋ฅผ ์ˆ˜ํ–‰ํ•  ์ˆ˜ ์žˆ๋„๋ก ์—ญ๋Ÿ‰์„ ๊ฐ•ํ™”ํ•˜์„ธ์š”.
ํ˜์‹ ์ ์ธ ํ›„๋ณด๋ฌผ์งˆ์„ ๋ฐœ๊ฒฌํ•˜๊ณ  ์ง„์ „์‹œํ‚ค์„ธ์š”. ํ˜์‹ ์ ์ธ ํ›„๋ณด๋ฌผ์งˆ์„ ๋ฐœ๊ฒฌํ•˜๊ณ  ์ง„์ „์‹œํ‚ค์„ธ์š”.
ํ˜์‹ ์ ์ธ ํ›„๋ณด๋ฌผ์งˆ์„ ๋ฐœ๊ฒฌํ•˜๊ณ  ์ง„์ „์‹œํ‚ค์„ธ์š”.
ํ˜์‹ ์„ฑ ๋ฐ ์ „๋ฌธ์„ฑ์„ ๋ฐ”ํƒ•์œผ๋กœ ๋ฆฌ๋”์‹ญ์„ ๋ฐœํœ˜ํ•˜๊ณ ,์‹ ๋ขฐํ•  ์ˆ˜ ์žˆ๋Š” ์ธ์‚ฌ์ดํŠธ๋ฅผ ํ™•๋ณดํ•ด R&D ์ „๋žต์„ ์ˆ˜๋ฆฝํ•˜์„ธ์š”.
R&D ์—์ฝ”์‹œ์Šคํ…œ ์ „๋ฐ˜์— ์ธํ…”๋ฆฌ์ „์Šค๋ฅผ ๊ฐ–์ถฐ ๊ฐœ๋ฐœ, ๊ทœ์ œ, ์•ˆ์ „ ๋“ฑ ์ „ ๊ณผ์ •์—์„œ ๋ณ€ํ™”๋ฅผ ์ด๋Œ ์ˆ˜ ์žˆ๋Š” ์ž์‹ ๊ฐ ์žˆ๋Š” ๊ฒฐ์ •์„ ๋‚ด๋ฆฌ์„ธ์š”.
ํ™˜์ž์— ๋„๋‹ฌํ•˜๋Š” ๊ฒฝ๋กœ๋ฅผ ์•ž๋‹น๊ธฐ์„ธ์š” ํ™˜์ž์— ๋„๋‹ฌํ•˜๋Š” ๊ฒฝ๋กœ๋ฅผ ์•ž๋‹น๊ธฐ์„ธ์š”
ํ™˜์ž์— ๋„๋‹ฌํ•˜๋Š” ๊ฒฝ๋กœ๋ฅผ ์•ž๋‹น๊ธฐ์„ธ์š”
์‹ ๋ขฐํ•  ์ˆ˜ ์žˆ๋Š” ๋งž์ถคํ˜• ์‹œ์žฅ ์ ‘๊ทผ ๋ฐ ์ถœ์‹œ ์†”๋ฃจ์…˜์œผ๋กœ ๋งค๋ฒˆ ์„ฑ๊ณต์ ์ธ ์ถœ์‹œ๋ฅผ ๋‹ฌ์„ฑํ•˜์„ธ์š”.
๋ฐ์ดํ„ฐ ๊ธฐ๋ฐ˜ ๋„๊ตฌ์™€ ์ „๋ฌธ ์ง€์‹์œผ๋กœ ์ƒ์—… ํŒ€์˜ ์—ญ๋Ÿ‰์„ ๊ฐ•ํ™”ํ•ด ์‹œ์žฅ์„ ํšจ๊ณผ์ ์œผ๋กœ ํƒ€๊ฒŸํŒ…ํ•˜๊ณ  ํ•„์š”ํ•œ ํ™˜์ž์—๊ฒŒ ์น˜๋ฃŒ์ œ๋ฅผ ์ œ๊ณตํ•  ์ˆ˜ ์žˆ๋„๋ก ์ง€์›ํ•˜์„ธ์š”.
๊ฒฐ๊ณผ๋ฅผ ์ธก์ •ํ•˜๊ณ , ๋ณดํ˜ธํ•˜๊ณ , ํ–ฅ์ƒ์‹œํ‚ค์„ธ์š”. ๊ฒฐ๊ณผ๋ฅผ ์ธก์ •ํ•˜๊ณ , ๋ณดํ˜ธํ•˜๊ณ , ํ–ฅ์ƒ์‹œํ‚ค์„ธ์š”.
๊ฒฐ๊ณผ๋ฅผ ์ธก์ •ํ•˜๊ณ , ๋ณดํ˜ธํ•˜๊ณ , ํ–ฅ์ƒ์‹œํ‚ค์„ธ์š”.
ํƒ์›”ํ•œ ์ธํ…”๋ฆฌ์ „์Šค์™€ ๊ฐ•๋ ฅํ•œ ์‹œ์žฅ ์ถ”์  ๋„๊ตฌ๋ฅผ ํ†ตํ•ด ์ œํ’ˆ์˜ ์ „์ฒด ์ƒ์•  ์ฃผ๊ธฐ ๋™์•ˆ ์„ฑ๊ณผ๋ฅผ ์ธก์ •ํ•˜๊ณ , ๋ณดํ˜ธํ•˜๋ฉฐ, ์„ฑ์žฅ์‹œํ‚ค์„ธ์š”.
์—…๊ณ„ ์ตœ๊ณ ์˜ ๋ฐ์ดํ„ฐ, ๋ถ„์„์ •๋ณด, ์ „๋ฌธ๊ฐ€, ๊ฐ•๋ ฅํ•œ ์ „์šฉ ๋„๊ตฌ๋ฅผ ํ™œ์šฉํ•˜์—ฌ ๊ฒฉ์ฐจ๋ฅผ ํ•ด์†Œํ•˜๊ณ  ์‹œ์žฅ ์ถœ์‹œ ์‹œ๊ฐ„์„ ๋‹จ์ถ•ํ•˜๋ฉฐ ์ƒ์—…์  ํšจ๊ณผ๋ฅผ ๊ทน๋Œ€ํ™”ํ•˜์„ธ์š”.

ํ—ฌ์Šค์ผ€์–ด ์—์ฝ”์‹œ์Šคํ…œ์„ ์œ„ํ•œ ์‹ ๋ขฐํ•  ์ˆ˜ ์žˆ๋Š” ํŒŒํŠธ๋„ˆ

ํด๋ž˜๋ฆฌ๋ฒ ์ดํŠธ๋Š” ๋ณ€ํ™”ํ•˜๋Š” ์„ธ์ƒ ์†์—์„œ ์˜๋ฃŒ ๋ถ„์•ผ์˜ ์ฃผ์š” ๊ณผ์ œ๋ฅผ ์˜ˆ์ธกํ•˜๊ณ  ํ•ด๊ฒฐํ•  ์ˆ˜ ์žˆ๋„๋ก ํ˜์‹ ์ ์ธ ์ธํ…”๋ฆฌ์ „์Šค๋ฅผ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ๊ทธ ๋ชจ๋“  ๊ณผ์ •์—์„œ ๊ฐ€์žฅ ์ค‘์š”ํ•œ ์‚ฌ๋žŒ- ์ฆ‰, ํ™˜์ž๋ฅผ ์ค‘์‹ฌ์— ๋‘๊ณ  ์ƒ๊ฐํ•ฉ๋‹ˆ๋‹ค.

3์ฒœ+
์ „์„ธ๊ณ„ ์ƒ๋ช…๊ณผํ•™ ๋ถ„์•ผ์˜
๊ณ ๊ฐ์‚ฌ ์ˆ˜
30
์„ธ๊ณ„ ์ตœ๊ณ ์˜ ์ œ์•ฝํšŒ์‚ฌ์˜
๊ณ ๊ฐ์‚ฌ ์ˆ˜
20
์„ธ๊ณ„ ์ตœ๊ณ ์˜ ์˜๋ฃŒ๊ธฐ๊ธฐ
ํšŒ์‚ฌ์˜ ๊ณ ๊ฐ์‚ฌ ์ˆ˜
10
์„ธ๊ณ„ ์ตœ๊ณ ์˜ ๋ฐ”์ด์˜คํ…
ํšŒ์‚ฌ์˜ ๊ณ ๊ฐ์‚ฌ ์ˆ˜

์„ธ๊ณ„ ์ตœ๊ณ  ์ˆ˜์ค€์˜ ๋ฐ์ดํ„ฐ์™€ ์ „๋ฌธ์„ฑ์„ ์—ฐ๊ฒฐํ•˜๋Š” ํ˜์‹ ์ ์ธ ์ธํ…”๋ฆฌ์ „์Šค๋กœ ํ™˜์ž ์น˜๋ฃŒ๊ฒฐ๊ณผ๋ฅผ ๊ฐœ์„ ํ•˜์„ธ์š”.

ํด๋ž˜๋ฆฌ๋ฒ ์ดํŠธ๋Š” ์ƒ๋ช…๊ณผํ•™ ๋ฐ ํ—ฌ์Šค์ผ€์–ด ์กฐ์ง์ด ์•ˆ์ „ํ•˜๊ณ  ํšจ๊ณผ์ ์ด๋ฉฐ ์ƒ์—…์ ์œผ๋กœ ์„ฑ๊ณต์ ์ธ ์น˜๋ฃŒ๋ฒ•๊ณผ ์†”๋ฃจ์…˜์„ ํ™˜์ž์—๊ฒŒ ๋” ๋น ๋ฅด๊ฒŒ ์ œ๊ณตํ•˜๋Š” ๋ฐ ํ•„์š”ํ•œ ์ƒํ™ฉ๋ณ„ ์ธํ…”๋ฆฌ์ „์Šค๋ฅผ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค.

ํ˜์‹ ์ ์ธ ์น˜๋ฃŒ๋ฒ• ๊ณ„ํšํ•˜๊ณ  ํฌํŠธํด๋ฆฌ์˜ค ์„ฑ์žฅ ์ถ”์ง„ํ•˜์„ธ์š”.

ํด๋ž˜๋ฆฌ๋ฒ ์ดํŠธ๋Š” ๋ฐ์ดํ„ฐ์™€ ์ „๋ฌธ ์ง€์‹์„ ์—ฐ๊ฒฐํ•ด,์น˜๋ฃŒ์˜ ์šฐ์„ ์ˆœ์œ„๋ฅผ ์ •ํ•  ์ˆ˜ ์žˆ๋Š” ์ธ์‚ฌ์ดํŠธ๋ฅผ ์ œ๊ณตํ•˜๋Š” ํ˜์‹ ์ ์ธ ์ธํ…”๋ฆฌ์ „์Šค๋ฅผ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค.

 

์ถ”์ฒœ ์ œํ’ˆ

Cortellis Competitive Intelligence

Make critical portfolio decisions backed by comprehensive pipeline and pharma competitive intelligence

Disease Landscape and Forecast

Maximize the value of your assets with in-depth indication-specific market intelligence

Cortellis Deals Intelligence

Negotiate your best deal with insights from pharma deals intelligence

์˜์•ฝํ’ˆ ์ƒ์•  ์ฃผ๊ธฐ๋ฅผ ์ „์ฒด๋ฅผ ์•„์šฐ๋ฅด๋Š” ํ˜์‹ ์ ์ธ ์ง€๋Šฅ์„ ํ†ตํ•ด ์ƒˆ๋กœ์šด ํ›„๋ณด ๋ฌผ์งˆ์„ ๋ฐœ์ „์‹œํ‚ค๊ณ , ๊ทœ์ œ ์Šน์ธ์„ ๋ณด์žฅํ•˜์„ธ์š”

์—ฐ๊ตฌ๊ฐœ๋ฐœ ์—์ฝ”์‹œ์Šคํ…œ ์ „๋ฐ˜์— ์‹ ์†ํ•˜๊ณ  ์ž์‹ ์žˆ๊ฒŒ ์˜์‚ฌ๊ฒฐ์ •์„ ๋‚ด๋ฆฌ๋Š” ๋ฐ ํ•„์š”ํ•œ ์ธํ…”๋ฆฌ์ „์Šค๋ฅผ ๊ฐ–์ถ”์„ธ์š”.

์ถ”์ „ ์ œํ’ˆ

Cortellis Drug Discovery Intelligence

Accelerate drug development with complete discovery and preclinical intelligence

Cortellis Regulatory Intelligence
๊ทœ์ œ ์ •๋ณด๋ฅผ ์ตœ์‹  ์ƒํƒœ๋กœ ์—…๋ฐ์ดํŠธ ํ•˜๊ณ , ์ œ์•ฝ๋ฐ”์ด์˜ค ๋ฐ Medtech ๊ทœ์ œ ์ค€์ˆ˜๋ฅผ ์œ ์ง€ํ•˜๋ฉฐ ์˜ฌ๋ฐ”๋ฅธ ์ „๋žต์  ์˜์‚ฌ๊ฒฐ์ •์„ ๋‚ด๋ฆด ์ˆ˜ ์žˆ๋„๋ก ์ง€์›ํ•ฉ๋‹ˆ๋‹ค.
OFF-X Translational Safety Intelligence
์œ„ํ—˜์„ ์˜ˆ์ธกํ•˜๊ณ  ์ƒˆ๋กœ์šด ๊ฒฝ์Ÿ๊ฐ€์น˜๋ฅผ ์ฐฝ์ถœํ•˜๊ธฐ ์œ„ํ•ด ์•ฝ๋ฌผ ๋ฐ ํด๋ž˜์Šค ์•ˆ์ •์„ฑ ์ธํ…”๋ฆฌ์ „์Šค๋ฅผ ์ œ๊ณตํ•˜๋Š” ๋…ํŠนํ•œ ์†”๋ฃจ์…˜์ž…๋‹ˆ๋‹ค.
Drug Safety Triager
ํด๋ž˜๋ฆฌ๋ฒ ์ดํŠธ์˜ ์•ฝ๋ฌผ๊ฐ์‹œ ๋ฌธํ—Œ ๊ฒ€ํ†  ์†Œํ”„ํŠธ์›จ์–ด๋Š” ์ƒ๋ช…๊ณผํ•™ ์กฐ์ง์ด ๊ทœ์ œ ์š”๊ฑด์„ ์ถฉ์กฑํ•  ์ˆ˜ ์žˆ๋„๋ก ์ง€์›ํ•ฉ๋‹ˆ๋‹ค.

์‹ ๋ขฐํ•  ์ˆ˜ ์žˆ๋Š” ์‹œ์žฅ ์ ‘๊ทผ ๋ฐ ์ถœ์‹œ ์†”๋ฃจ์…˜์œผ๋กœ ์‹œ์žฅ๊ณผ ํ™˜์ž์—๊ฒŒ ๋” ๋น ๋ฅด๊ฒŒ ๋‹ค๊ฐ€๊ฐ€์„ธ์š”.

ํ•„์š”ํ•œ ํ™˜์ž์—๊ฒŒ ๊ท€์‚ฌ์˜ ์น˜๋ฃŒ์ œ๊ฐ€ ์ „๋‹ฌ๋  ์ˆ˜ ์žˆ๋„๋ก ์ƒ์—…์  ์ „๋ฌธ์„ฑ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค.

์ถ”์ฒœ ์ œํ’ˆ

Fingertip Formulary Suite
๋Œ€ํ™”ํ˜• ๋„๊ตฌ๋ฅผ ํ†ตํ•ด ๋ธŒ๋žœ๋“œ์™€ ๊ฒฝ์Ÿ์‚ฌ๋ฅผ ์ถ”์ ํ•  ์ˆ˜ ์žˆ๋Š” ์ปค๋ฒ„๋ฆฌ์ง€ ๋ฐ ์ •์ฑ… ๋ฐ์ดํ„ฐ๋ฅผ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค.
Managed Market Surveyor Suite
์ •ํ™•ํ•œ ๋ฏธ๊ตญ ๋งค๋‹ˆ์ง€๋“œ ์ผ€์–ด ๋“ฑ๋ก ๋ฐ์ดํ„ฐ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ์‹œ์žฅ ์ง„์ถœ ์ „๋žต์„ ์ˆ˜๋ฆฝํ•˜์„ธ์š”.
Market Overviews
์ฃผ์š” ํ—ฌ์Šค์ผ€์–ด ์—…์ฒด ๋ฐ ์‹œ์žฅ ๋™์ธ์— ๋Œ€ํ•œ ์—„์„ ๋œ ์ง๊ด€์ ์ธ ๋ถ„์„ ์ •๋ณด๋ฅผ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค.
Healthbase
์—…๊ณ„์—์„œ ๊ฐ€์žฅ ์ •ํ™•ํ•˜๊ณ  ์Šค๋งˆํŠธํ•œ ์ œํœด ํ”Œ๋žซํผ์ž…๋‹ˆ๋‹ค.

Title – page not final

Subtitle, page not final

 

Cortellis Product Intelligence
๋น„์ฆˆ๋‹ˆ์Šค๋ฅผ ์„ฑ์žฅ์‹œํ‚ค๊ณ  ๊ฒฌ๊ณ ํ•œ ๊ณต๊ธ‰๋ง์„ ๊ตฌ์ถ•ํ•˜์„ธ์š”.
Cortellis CMC Intelligence
์˜์•ฝํ’ˆ ๊ฐœ๋ฐœ์€ ์–ด๋ ต์Šต๋‹ˆ๋‹ค. ํ•˜์ง€๋งŒ ์ถœ์‹œ๊ฐ€ ์ด๋ณด๋‹ค ์–ด๋ ค์›Œ์„œ๋Š” ์•ˆ๋ฉ๋‹ˆ๋‹ค.

๊ณ ๊ฐ์˜ ํ•„์š”์— ๋งž์ถ˜ ์ œํ’ˆ๊ณผ ์ „๋ฌธ๊ฐ€ ์ปจ์„คํŒ…์„ ๊ฒฐํ•ฉํ•œ ๋…ํŠนํ•œ ์„œ๋น„์Šค๋ฅผ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค.

๋ฐ์ดํ„ฐ ๋ถ„์„ ๊ธฐ๋Šฅ์ด ํ•„์š”ํ•˜๋“ , ๋™์  ๋Œ€์‹œ๋ณด๋“œ๋‚˜ ๋งž์ถคํ˜• ๋ฐ์ดํ„ฐ ์ธ์‚ฌ์ดํŠธ์™€ ์„œ๋น„์Šค๊ฐ€ ํ•„์š”ํ•˜๋“ , ํด๋ž˜๋ฆฌ๋ฒ ์ดํŠธ๋Š” ์—ฌ๋Ÿฌ๋ถ„์˜ ์„ฑ๊ณต์„ ์œ„ํ•ด ํ•จ๊ป˜ํ•˜๊ฒ ์Šต๋‹ˆ๋‹ค.

 

์ „๋ฌธ๊ฐ€ ๊ธฐ๋ฐ˜์˜ ๋ฐ์ดํ„ฐ์™€ ์ธ์‚ฌ์ดํŠธ๋ฅผ ๊ธฐ๋ฐ˜์œผ๋กœ Medtech ํ˜์‹ ์„ ์ด‰์ง„ํ•˜๊ณ , ์˜๋ฃŒ๊ธฐ๊ธฐ ๋ฐ ์ง„๋‹จ ํšŒ์‚ฌ๋“ค์ด ์„ธ์ƒ์„ ๋ณ€ํ™”์‹œํ‚ฌ ์ˆ˜ ์žˆ๋„๋ก ์ง€์›ํ•ฉ๋‹ˆ๋‹ค.

์—ฐ๊ฒฐ๋œ ๋ฐ์ดํ„ฐ, ๊ณ ๊ธ‰ ๋ถ„์„, ํšจ์œจ์ ์ธ ์›Œํฌํ”Œ๋กœ์šฐ๋ฅผ ํ†ตํ•ด ์‹œ์žฅ ์ถœ์‹œ์™€ ํ™˜์ž์—๊ฒŒ ๋„๋‹ฌํ•˜๋Š” ์‹œ๊ฐ„์„ ๊ฐ€์†ํ™”ํ•˜์„ธ์š”.

 

 

๊ณ ๊ฐ์˜ ์†Œ๋ฆฌ

์ €๋Š” ํด๋ž˜๋ฆฌ๋ฒ ์ดํŠธ๊ฐ€ ํ•ญ์ƒ ํ’๋ถ€ํ•œ ์—ฐ๊ตฌ์™€ ๊นŠ์ด ์žˆ๋Š” ์‚ฌ๊ณ ๋ฅผ ๋ฐ”ํƒ•์œผ๋กœ ์ƒˆ๋กœ์šด ์ ‘๊ทผ ๋ฐฉ์‹์„ ์ œ์‹œํ•œ๋‹ค๊ณ  ๋ฏฟ์Šต๋‹ˆ๋‹ค. ํ†ต์ฆ ๋ถ„์•ผ์˜ ํ™˜์ž ์ค‘์‹ฌ ์ด๋‹ˆ์…”ํ‹ฐ๋ธŒ๋ฅผ ๋‹ค๋ฅธ ์น˜๋ฃŒ ์˜์—ญ์œผ๋กœ๋„ ํ™•์žฅํ•ด ๋‚˜๊ฐ€๊ธฐ๋ฅผ ๊ธฐ๋Œ€ํ•ฉ๋‹ˆ๋‹ค.

Ankur Gupta ๋ฐ•์‚ฌ ์ง€์—ญ ์˜ํ•™๋ถ„์•ผ ๋‹ด๋‹น ์ด์‚ฌr
Menarini

ํด๋ž˜๋ฆฌ๋ฒ ์ดํŠธ๋Š” ์ถ”์  ์• ํ”Œ๋ฆฌ์ผ€์ด์…˜์„ ์‚ฌ์šฉํ•  ๋•Œ ์šฐ๋ฆฌ๊ฐ€ ํ•„์š”๋กœ ํ•˜๋Š” ๊ฒƒ๋“ค์„ ์ถฉ๋ถ„ํžˆ ๋ฐ˜์˜ํ•ด ์ฃผ์—ˆ๊ณ , ํ•ญ์ƒ ์‹ ์†ํ•˜๊ณ  ์นœ์ ˆํ•˜๊ฒŒ ๋Œ€์‘ํ•ด ์ฃผ์—ˆ์Šต๋‹ˆ๋‹ค. ๋•๋ถ„์— ์ด์ œ ์šฐ๋ฆฌ๋Š” ๊ทœ์ œ ์•Œ๋ฆผ์„ ํšจ์œจ์ ์œผ๋กœ ์ฒ˜๋ฆฌํ•˜๊ณ  ๊ด€๋ฆฌํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ๋‰ด์Šค๋ ˆํ„ฐ ๋ฐœ์†ก๋„ ํ›จ์”ฌ ๋” ์ˆ˜์›”ํ•˜๊ฒŒ ํ•  ์ˆ˜ ์žˆ๊ฒŒ ๋˜์—ˆ์Šต๋‹ˆ๋‹ค.

Kinga Pallay ๊ทœ์ œ์ •๋ณด ์ „๋ฌธ๊ฐ€, Gedeon Richter

chevron_left
chevron_right
Menarini-๋ธŒ๋žœ๋“œ ์ „๋žต์— ํ™˜์ž ์ค‘์‹ฌ ์ ‘๊ทผ ๋ฐฉ์‹์„ ํ†ตํ•ฉํ•ด ์ƒ์—…์  ์šฐ์ˆ˜์„ฑ์„ ๋‹ฌ์„ฑ
Menarini-๋ธŒ๋žœ๋“œ ์ „๋žต์— ํ™˜์ž ์ค‘์‹ฌ ์ ‘๊ทผ ๋ฐฉ์‹์„ ํ†ตํ•ฉํ•ด ์ƒ์—…์  ์šฐ์ˆ˜์„ฑ์„ ๋‹ฌ์„ฑ
์ƒ์• ์ฃผ๊ธฐ ์ค‘๊ฐ„์— ๋„๋‹ฌํ•œ ์ž์‚ฐ์— ๋Œ€ํ•œ ์ƒˆ๋กœ์šด ์ฆ๊ฑฐ๋ฅผ ์ƒ์„ฑํ•˜๋Š” ์ƒˆ๋กœ์šด ๋ฐฉ๋ฒ•์„ ์ฐพ์€ ๋ฐฉ๋ฒ•์— ๋Œ€ํ•ด ์•Œ์•„๋ณด์„ธ์š”.
์œ ๋Ÿฝ์˜ ์‹ฌ์žฅ๋ถ€์—์„œ ์ƒ์„ฑ๋œ ์ œ์•ฝ ์ด์•ผ๊ธฐ
์œ ๋Ÿฝ์˜ ์‹ฌ์žฅ๋ถ€์—์„œ ์ƒ์„ฑ๋œ ์ œ์•ฝ ์ด์•ผ๊ธฐ
Gedeon Richter๊ฐ€ ํด๋ž˜๋ฆฌ๋ฒ ์ดํŠธ์™€ ํ˜‘๋ ฅํ•ด ๊ทœ์ œ ์›Œํฌํ”Œ๋กœ๋ฅผ ํ˜์‹ ํ•œ ๋ฐฉ๋ฒ•์„ ์•Œ์•„๋ณด์„ธ์š”.

๋น„๊ตํ•  ์ˆ˜ ์—†๋Š” ์ „๋ฌธ์„ฑ

์น˜๋ฃŒ ๋ถ„์•ผ ์ „๋ฌธ๊ฐ€, ๋ฐ์ดํ„ฐ ๊ณผํ•™์ž, ์•ฝ์‚ฌ ๋“ฑ 400๋ช… ์ด์ƒ์˜ ์ „๋ฌธ ์ธ๋ ฅ๊ณผ ํฌ๊ด„์ ์ธ ์น˜๋ฃŒ ์˜์—ญ๋ณ„ ๋ฐ์ดํ„ฐ๋ฅผ ๋ฐ”ํƒ•์œผ๋กœ, ์˜๋ฃŒ ๋ถ„์•ผ์˜ ๊ฐ€์žฅ ํฐ ๋„์ „ ๊ณผ์ œ๋ฅผ ํ•ด๊ฒฐํ•  ์ค€๋น„๊ฐ€ ๋˜์–ด ์žˆ์Šต๋‹ˆ๋‹ค.

์ „ ์„ธ๊ณ„ ๋ณด๊ฑด๊ณผ ํ™˜์ž์˜ ์‚ถ์— ์ง€์†์ ์ธ ์˜ํ–ฅ๋ ฅ ๋ฐœํœ˜

ํด๋ž˜๋ฆฌ๋ฒ ์ดํŠธ์˜ ์ตœ์‹  ์ƒ๋ช…๊ณผํ•™ ๋ฐ ํ—ฌ์Šค์ผ€์–ด ์ธ์‚ฌ์ดํŠธ์™€ ์ „๋ฌธ๊ฐ€ ๋ถ„์„์„ ํ™•์ธํ•˜์„ธ์š”.

๋ณด๊ณ ์„œ

์ฃผ๋ชฉํ•ด์•ผ ํ•  ์‹ ์•ฝ ๋ณด๊ณ ์„œ 2024

Report

2024๋…„ ์ฃผ๋ชฉํ•ด์•ผ ํ•  ์˜๋ฃŒ๊ธฐ์ˆ 

Report

7๊ฐœ์˜ ADC ๊ธฐ์—…๋“ค์ด ๋‚œ์น˜์„ฑ ์•”์— ๋Œ€ํ•œ ์ƒˆ๋กœ์šด ๊ฐ€๋Šฅ์„ฑ์„ ๋ณด์—ฌ์ฃผ๋Š” ์น˜๋ฃŒ์ œ๋ฅผ ๊ฐœ๋ฐœํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.

์ฃผ๋ชฉํ•ด์•ผ ํ•  ์‹ ์•ฝ ๋ณด๊ณ ์„œ 2024 ์ฃผ๋ชฉํ•ด์•ผ ํ•  ์‹ ์•ฝ ๋ณด๊ณ ์„œ 2024
์ฃผ๋ชฉํ•ด์•ผ ํ•  ์‹ ์•ฝ ๋ณด๊ณ ์„œ 2024
ํด๋ž˜๋ฆฌ๋ฒ ์ดํŠธ ์ฃผ๋ชฉํ•ด์•ผ ํ•  ์‹ ์•ฝ ๋ณด๊ณ ์„œ๋Š” ์ตœ๊ทผ ์ถœ์‹œ๋˜์—ˆ๊ฑฐ๋‚˜ ๊ณง ์ถœ์‹œ๋  ์•ฝ๋ฌผ ์ค‘ ์น˜๋ฃŒ ํŒจ๋Ÿฌ๋‹ค์ž„์„ ๋ฐ”๊พธ๊ฑฐ๋‚˜ 5๋…„ ์ด๋‚ด์— ๋ธ”๋ก๋ฒ„์Šคํ„ฐ ์ง€์œ„์— ๋„๋‹ฌํ•  ๊ฐ€๋Šฅ์„ฑ์ด ์žˆ๋Š” ์•ฝ๋ฌผ์„ ์ง‘์ค‘ ์กฐ๋ช…ํ•ฉ๋‹ˆ๋‹ค.
2024๋…„ ์ฃผ๋ชฉํ•ด์•ผ ํ•  ์˜๋ฃŒ๊ธฐ์ˆ  2024๋…„ ์ฃผ๋ชฉํ•ด์•ผ ํ•  ์˜๋ฃŒ๊ธฐ์ˆ 
2024๋…„ ์ฃผ๋ชฉํ•ด์•ผ ํ•  ์˜๋ฃŒ๊ธฐ์ˆ 

7๊ฐœ์˜ ADC ๊ธฐ์—…๋“ค์ด ๋‚œ์น˜์„ฑ ์•”์— ๋Œ€ํ•œ ์ƒˆ๋กœ์šด ๊ฐ€๋Šฅ์„ฑ์„ ๋ณด์—ฌ์ฃผ๋Š” ์น˜๋ฃŒ์ œ๋ฅผ ๊ฐœ๋ฐœํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค. 7๊ฐœ์˜ ADC ๊ธฐ์—…๋“ค์ด ๋‚œ์น˜์„ฑ ์•”์— ๋Œ€ํ•œ ์ƒˆ๋กœ์šด ๊ฐ€๋Šฅ์„ฑ์„ ๋ณด์—ฌ์ฃผ๋Š” ์น˜๋ฃŒ์ œ๋ฅผ ๊ฐœ๋ฐœํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.
Blog June 19, 2024
7๊ฐœ์˜ ADC ๊ธฐ์—…๋“ค์ด ๋‚œ์น˜์„ฑ ์•”์— ๋Œ€ํ•œ ์ƒˆ๋กœ์šด ๊ฐ€๋Šฅ์„ฑ์„ ๋ณด์—ฌ์ฃผ๋Š” ์น˜๋ฃŒ์ œ๋ฅผ ๊ฐœ๋ฐœํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.

์ตœ๊ทผ์˜ ํ•ญ์ฒด ์•ฝ๋ฌผ ์ ‘ํ•ฉ์ฒด(ADC) ์—ดํ’์ด ๋ถˆ๊ธฐ๊นŒ์ง€๋Š” ๊ธธ๊ณ  ๋А๋ฆฐ ์—ฌ์ •์„ ๊ฑฐ์ณค์Šต๋‹ˆ๋‹ค. 60๋…„์ „ ์‹คํ—˜์ ์ธ ADC์„ค๊ณ„๊ฐ€ ์ฒ˜์Œ ๋ฐœํ‘œ๋œ ํ›„ ์ž„์ƒ์‹œํ—˜์ด ์‹œ์ž‘๋˜๊ธฐ๊นŒ์ง€ 20๋…„์ด ๊ฑธ๋ ธ๊ณ , ์ฒซ ๋ฒˆ์งธ ๊ทœ์ œ ์Šน์ธ์„ ๋ฐ›๋Š” ๋ฐ๋Š” 40๋…„์ด ๊ฑธ๋ ธ์Šต๋‹ˆ๋‹ค. ๊ทธ๋Ÿฌ๋‚˜, ์ฒซ๋ฒˆ์งธ…

Need title please

Need subtitle please

Seven companies forging new paths in womenโ€™s health Seven companies forging new paths in womenโ€™s health
Blog November 13, 2025
Seven companies forging new paths in womenโ€™s health
Six companies enabling precision interventions for โ€œundruggableโ€ targets Six companies enabling precision interventions for โ€œundruggableโ€ targets
Blog October 7, 2025
Six companies enabling precision interventions for โ€œundruggableโ€ targets
GLP-1 weight loss access comes down to a dogfight in the U.S. GLP-1 weight loss access comes down to a dogfight in the U.S.
Blog October 3, 2025
GLP-1 weight loss access comes down to a dogfight in the U.S.
How Clarivate works towards SDG 3: good health and well-being through antimicrobial stewardship How Clarivate works towards SDG 3: good health and well-being through antimicrobial stewardship
Blog September 22, 2025
How Clarivate works towards SDG 3: good health and well-being through antimicrobial stewardship
chevron_left
chevron_right